Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam oral solution + dexmedetomidine vs chloral hydrate + dexmedetomidine for MRI sedation in children
ChiCTR2600121358Phase 4Not yet recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anxiety disorder and None comparing Midazolam oral solution + intranasal dexmedetomidine with Oral chloral hydrate + intranasal dexmedetomidine (2 arms). Primary endpoint: Success rate of sedation after completing the examination. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
midazolamdexmedetomidinechloral hydrate
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2600121358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121358.